Psychiatry and the 'new genetics': Hunting for genes for behaviour and drug response

British Journal of Psychiatry

Volumn 186, Issue FEB., 2005, Pages 91-92

  Aitchison, Katherine J ^a   Basu, Amlan ^b   McGuffin, Peter ^b   Craig, Ian ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CLOZAPINE; CYTOCHROME P450 1A2; CYTOCHROME P450 2D6; DOPAMINE 2 RECEPTOR; NEUROLEPTIC AGENT;

ALLELE; ANXIETY DISORDER; CHROMOSOMAL PARAMETERS; COGNITION; DEPRESSION; DOPAMINERGIC TRANSMISSION; DRUG CHOICE; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG RESPONSE; EDITORIAL; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC MARKER; GENOTYPE; HUMAN; LANGUAGE DEVELOPMENT; LINKAGE ANALYSIS; MEDICAL DECISION MAKING; PHARMACODYNAMICS; PHARMACOGENETICS; PSYCHIATRY; QUANTITATIVE TRAIT LOCUS; SEROTONINERGIC TRANSMISSION; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; X CHROMOSOME LINKAGE;

GENETICS, BEHAVIORAL; HUMANS; MENTAL DISORDERS; PHARMACOGENETICS;

EID: 13244255690     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.186.2.91     Document Type: Editorial

References (11)

1. Aitchison, K. J. & Gill, M. (2003) Pharmacogenetics in the postgenomic era. In Behavioral Genetics in the Postgenomic Era (eds R. Plomin, J. C. Defries, I. W. Craig & P. McGuffin), pp. 335-361. Washington, DC: American Psychological Association.
2. Aitchison, K. J., Gonzalez, F. J., Quattrochi, L. C., et al (2000) Identification of novel polymorphisms in the 5′' flanking region of CYPIA2, characterisation of interethnic variabiiity, and investigation of their functional significance. Pharmacogenetics, 10, 695-704.
3. Basu, A., Tsapakis, E. & Aichison, K. J. (2004) Pharmacogenetics and psychiatry. Current Psychiatry Reports, 6, 134-142.
4. Butcher, L. H., Meaburn, E., Dale, P. S., et al (2004a) Association analysis of mud mental impairment using DNA pooling to screen 432 brain-expressed single-nucleotide polymorphisms. Molecular Psychiatry, in press.
5. Butcher, L. M., Meaburn, E., Liu, L., et al (2004b) Genotyping pooled DNA on microarrays: a systematic genome screen of thousands of SNPs in large samples to detect QTLs for complex traits. Behavior Genetics, 34, 549-555.
6. Caspi, A., McClay, J., Moffitt, T. E., et al (2002) Role of genotype in the cycle of violence in maltreated children. Science, 297, 851-854.
7. Caspi, A., Sugden, K., Moffitt, T. E., et al (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene, Science, 301, 386-389.
8. Crag, I. W., Mill, J., Craig, G. H., et al (2004) Application of micro-assays to the analysis of the inactivation status of human X-linked genes expressed in lymphocytes. European Journal of Human Genetics, 12, 639-646.
9. Eley, T. C., Sugden, K., Corsica, A., et al (2004) Gene-environment interaction analysis of serotonin system markers with adolescent depression. Molecular Psychiatry, 9, 908-915.
10. Loat, C. S., Asbury, K., Galsworthy, M. J., et al (2004) X inactivation as a source of behavioural differences in monozygotic female twins. Twin Research, 7, 54-61.
11. Nash, M. W., Huezo-Diaz, P., Williamson, R. J., et al (2004) Genome-wide linkage analysis of a composite index of neuroticism and mood-related scales in extreme selected sibships. Human Molecular Genetics, 13, 2173-2182.